Stent Graft Balloon Catheter Market Forecast 2026-2036: Market to Reach USD 2,160.7 Million by 2036 at 6.8% CAGR

NEWARK, DE -The global stent graft balloon catheter market was valued at USD 1,047.9 million in 2025. Future Market Insights projects the market to expand from USD 1,119.2 million in 2026 to USD 2,160.7 million by 2036, reflecting a steady compound annual growth rate (CAGR) of 6.8% over the forecast period. This sustained expansion underscores the growing clinical preference for minimally invasive endovascular techniques in treating vascular conditions such as aortic aneurysms and peripheral arterial disease, where stent graft balloon catheters enable precise deployment, expansion, and post-dilation of stent grafts.

Read Full Report:https://www.futuremarketinsights.com/reports/stent-graft-balloon-catheter-market

Market snapshot: global market 2026 - 2036

Market size in 2026? USD 1,119.2 million
Market size in 2036? USD 2,160.7 million
CAGR (2026-2036)? 6.8%
Leading product segment(s) and shares? Non-compliant balloon stent catheter holds 63.5% value share in 2025 (leading segment due to high-pressure performance and precision in vascular procedures)
Leading material type and share? Not specified in source
Leading end use and share? Hospitals hold 36.4% value share in 2025 (leading due to advanced infrastructure and comprehensive patient care capabilities)
Key growth regions? China (fastest-growing), United States, India, Germany, Japan
Top companies? Medtronic, Boston Scientific, Abbott Laboratories, Cordis, Cook Medical, W. L. Gore & Associates Inc., Terumo Corporation, Atrium Medical, JOTEC GmbH, QXMédical, LLC, and others

Market Momentum (YoY Path)

The stent graft balloon catheter market demonstrates consistent forward momentum. Starting from USD 1,047.9 million in 2025, the market advances to USD 1,119.2 million in 2026. Growth continues steadily toward higher values in subsequent years, reaching an estimated trajectory that supports USD 2,160.7 million by 2036. Intermediate milestones include progressive increases through 2028, 2030, 2031, 2033, and 2035, delivering an absolute dollar growth of USD 1,041.6 million over the decade as clinical adoption of minimally invasive endovascular repair accelerates.

Why the Market is Growing

The stent graft balloon catheter market expands due to the rising prevalence of peripheral arterial disease and aortic aneurysms, combined with aging populations worldwide. A clear shift toward minimally invasive endovascular repair over traditional open surgery drives higher procedure volumes. Integration of AI-powered diagnostic tools, such as CathWorks' FFRangio system, enhances precision in balloon-based interventions and supports increased clinical confidence.

Segment Spotlight

Product Type Non-compliant balloon stent catheters lead the stent graft balloon catheter market with a 63.5% value share in 2025. Engineered for high-pressure dilation, these catheters deliver precise and controlled stent expansion - essential for treating complex vascular conditions like aortic aneurysms and peripheral artery disease. Advances in balloon material technology further improve durability and performance, reinforcing their dominance in challenging procedures.

Material Type Source does not provide specific material type segmentation or leading shares for the stent graft balloon catheter market; focus remains on balloon compliance categories (compliant, semi-compliant, non-compliant) rather than raw materials.

End Use Hospitals command a 36.4% value share in the stent graft balloon catheter market in 2025 and exhibit the highest CAGR in the forecast period. Equipped with advanced infrastructure, specialized cardiology capabilities, and comprehensive post-procedure care, hospitals perform the majority of endovascular interventions for vascular diseases, making them the preferred setting for complex and high-risk cases.

Drivers, Opportunities, Trends, Challenges

Drivers Rising demand for minimally invasive vascular procedures propels adoption of stent graft balloon catheters, as they offer shorter hospital stays, faster recovery, lower infection risk, and reduced costs compared to open surgery. Increasing prevalence of vascular diseases among aging populations further accelerates clinical uptake.

Opportunities Technological advancements - including high-strength materials, optimized inflation mechanisms, drug-eluting capabilities, and real-time 3D imaging - create opportunities to improve procedural success rates and patient outcomes. Expansion of hospital catheterization laboratories in high-growth markets like China and India opens new volume potential.

Trends The stent graft balloon catheter market sees growing integration of AI-guided systems and precision navigation tools. Larger-profile delivery systems, supported by innovations such as expanded PTFE liners, address complex anatomies and broaden clinical applications.

Challenges Increasing competition among manufacturers creates pricing pressure, particularly in mature markets, which can impact profitability. Sourcing fragility for key components like PTFE liners and catheter-grade polymers, along with stringent regulatory requirements (FDA 510(k)/PMA, CE marking), pose barriers for new entrants and require sustained clinical evidence generation.

Country Growth Outlook (CAGR)

China: 8.5% (2026-2036)
India: 9.2% (2026-2036)
Germany: 2.5% (2026-2036)
France: Not specified in source
UK: 5.8% (2026-2036)
USA: 2.9% (2026-2036)
Brazil: Not specified in source

Competitive Landscape

Power in the stent graft balloon catheter market remains concentrated among tier-1 players such as Medtronic, Boston Scientific, Abbott Laboratories, and Cordis (39.7% global share), who maintain extensive portfolios, strong R&D, and bundled stent-graft-plus-catheter systems. Tier-2 companies including Cook Medical, W. L. Gore & Associates Inc., Terumo Corporation, and Atrium Medical (26.2% share) focus on regional penetration and cost-effective solutions. Key players prioritize FDA approvals, strategic partnerships, advanced materials, and precision engineering to differentiate offerings.

Scope of the Report

Quantitative Units: Revenue in USD (USD 1,119.2 million in 2026 to USD 2,160.7 million in 2036, at a CAGR of 6.8%)
Market Definition: Covers manufacture, sale, and clinical use of balloon catheters for stent graft deployment, expansion, and post-dilation in endovascular procedures
Segmentation: Product type (compliant, semi-compliant, non-compliant balloon stent catheters); End user (hospitals, cardiac centers, ambulatory surgical centers); Applications (aortic aneurysm repair, peripheral vascular intervention, coronary intervention, others)
Regions Covered: North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa
Countries Covered: United States, Germany, France, United Kingdom, Japan, China, India, South Korea, Australia, Brazil, and 30+ countries
Key Companies Profiled: Medtronic, Cook Medical, W.L. Gore, Boston Scientific, Terumo Corporation, Shockwave Medical, Cagent Vascular, Junkosha, Artivion, Heartflow Inc., and others

Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1628

Get Access of Report Sample:https://www.futuremarketinsights.com/reports/sample/rep-gb-1628

FAQ

What is the projected size of the stent graft balloon catheter market in 2036? The global stent graft balloon catheter market is projected to reach USD 2,160.7 million by 2036.

What CAGR is expected for the stent graft balloon catheter market from 2026 to 2036? The market is expected to grow at a CAGR of 6.8% during 2026-2036.

Which product segment leads the stent graft balloon catheter market? Non-compliant balloon stent catheters lead with a 63.5% value share in 2025, driven by their high-pressure performance and precision.

Which end user segment holds the largest share? Hospitals account for 36.4% of the market in 2025, supported by advanced infrastructure and high procedure volumes.

Which countries show the strongest growth outlook? India (9.2% CAGR) and China (8.5% CAGR) represent the fastest-growing markets through 2036.

Explore More Related Studies Published by FMI Research:

Demand for Medical Bionic Implant and Artificial Organs in Japan: https://www.futuremarketinsights.com/reports/japan-medical-bionic-implant-and-artificial-organs-market

Electrophysiology Market: https://www.futuremarketinsights.com/reports/electrophysiology-market

Triple Therapy Inhalers Market: https://www.futuremarketinsights.com/reports/triple-therapy-inhalers-market

Disease-Modifying MS Therapies Market: https://www.futuremarketinsights.com/reports/disease-modifying-ms-therapies-market

Vitamins and Minerals Based Injectables Market: https://www.futuremarketinsights.com/reports/vitamins-and-minerals-based-injectables-market

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

This release was published on openPR.